Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-002674

Options or other derivatives

  • Chief Medical Officer acquired 1,052,028 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Amado Rafael Chief Medical Officer 2018-01-12 Grant or award · Option to purchase Ordinary Shares +859,968 859,968 D
Amado Rafael Chief Medical Officer 2018-01-12 Grant or award · Option to purchase Ordinary Shares +192,060 192,060 D
Loading xslF345X03/a4.xml…